当前位置: 论文资料 >> 医药学论文 >> 医学 >> 体外循环中肝素涂层管道应用的进展
体外循环中肝素涂层管道应用的进展

参考文献:



[1]GottVL,WhiffenJD,DuttenRC.Heparinbondingcolloidalgraphite

surfaces[J].Science,1963,142:1279-1298.



[2]BaufretonC,MoczarM,IntratorL,etal.Inflammatoryresponseto

CPBusingtwodifferenttypesofheparin-coatedextrocorporealcircuit

s[J].Perfusion,1998,13:419-427.



[3]MoenO,FosseE,BrockmeierV,etal.Disparityinbloodactivati

onbytwodifferentheparin-coatedCPBsystem[J].AnnThoracSurg199

5;60:1317-1323.



[4]θvrumE,MollnesTE,FosseE,etal.Complementandgranulocyte

activationintwodifferenttypesofheparinizedextracorporealcircuit

s[J].JThoracCardiovascSurg1995,110:1623-1632.



[5]MahoneyCB.Heparin-bondingcircuits:clinicaloutcomesandcosts

[J].Perfusion1998,13:192-204.



[6]OvrumE,TangenG,OysteseR,etal.Comparisonoftwoheparin-coa

tedextracorporealcircuitswithreducedsystemicanticoagulationinro

utinecoronaryarterybypassoperations[J].JThoracCardiovascSurg

2001Feb;121(2):324-330.



[7]ShigemitsuO,HadamaT,TakasakiH,etal.Biocompatibilityofa

heparin-bondedmembraneoxygentor(CarmedaMAXIMA)duringthefirst90m

inutesofcardiopulmonarybypass:clinicalcomparisonwiththeconventi

onalsystem[J].ArtifOrgans,1994,18L936-941.



[8]KhuriSF,ValeriCR,LoscalzoJ,etal.Heparincausesplateletdy

sfunctionandinducesfibrinolysisbeforecardiopulmonarybypass[J].

AnnThoracSurg,1995,60:1008-1014.



[9]CavarocchiNC,SchaffHV,OrszulakTA,etal.Evidenceforcomplem

entactivationbyheparin-protamininteractionafterCPB.Surgery,198

5,98:525-531.



[10]KornRL,FisherCA,LivingstonER,etal.TheeffectsofCBASon

humanbloodcomponentsduringsimulatedextracorporealcirculation[J]

.JThoracCardiovascSurg1996,111:1073-1084.



[11]PeknaM,HagmanL,HeldenE,etal.Complementactivationduring

CPB:effectsofimmobilizedheparin[J].AnnThoracSurg1994,58:421-4

24.



[12]qvrumE,MollnesTE,FosseE,etal.Highandlowheparindosew

ithheparin-coatedCPB:activationofcomplementandgranulocyte[J].

AnnThoracSurg1995,60:1755-1761.



[13]FosseE,MoenO,JohnsonE,etalReducedcomplementandgranuloc

yteactivationwithheparin-coatedCPB[J].AnnThoracSurg1994,58:

472-477.



[14]qvrumE,BrosstadF,HolenEA,etal.Effectsoncoagulationand

fibrinolysiswithreducedversusfullsystemicheparinizationandhepa

rin-coatedCPB.Circulation.1995,92:2579-2584.



[15]AlderGS,DoursounianM,GaraPO,etal.Heparin-bondedcircuits

withareducedanticoagulationprotocolinprimaryCABG:aprospective,

randomizedstudy[J].AnnThoracSurg1996,62:410-418.



[16]SeggesserLK,WeissBM,PasicM,etal.Riskandbenefitoflows

ystemicheparinizationduringopenheartoperations[J].AnnThoracS

urg1994;58:391-398



[17]VonSeggesserLK,WeissBM,GarciaE,etal.Reducedbloodlossa

ndtransfusionrequirementswithlowsystemicheparinization:prelimina

ryclinicalresultsincoronaryarteryrevascularization[J].EurJC

ardio-ThoracSurg1990,4:639-643.



[18]qvrumE,HolenEA,TangenG,etal.CompletelyheparinizedCPBan

dreducedsystemicheparin:clinicalandhemostaticeffects[J].Ann

ThoracSurg1995;60:365-371.



[19]VidemV,SvennevigJL,FosseE,etal.Reducedcomplementactivat

ionwithheparin-coatedoxygenatorandtubingincoronarybypassoperat

ion[J].JThoracCardiovascSurg1992,103:806-813.



[20]DowlingRD,BrownME,WhattingtonRO,etal.ClinicalCPBwithout

systemicanticoagulation[J].AnnThoracSurg1993,56:1176-1178.



21]BennettJ,HillJ,ParsonsJ,etal.Heparin-freecardiopulmonarys

upportutilizingacamedacoatedcircuitforapatientwithpulmonaryh

emorrhageandmultipletrauma[J].AMSECT29thInternationalConferenc

e,SanFrancisco,California,1991,Mar.1-4:15.



[22]VonSegesserLK,GarciaE,TurinaM.Perfusionwithoutsystemich

eparinizationforrewarminginaccidentalhypothermia[J].AnnThorac

Surg,1991,52:560-561.



[23]SaitoA,HayashiJ,EguchiS.Mechanicalcirculatoryassistusing

heparin-coatedtubeandrollerpumpsystem[J].AnnThoracSurg,19

92,53:659-665.



[24]FjalldalO,TorfasonPT,etal.Prolongedtotalextracorporeallu

ngassistancewithoutsystemicheparinization[J].ActaAnaesthesiol

Scand,1993,37:115-120.



[25]HayashiY,OhtakeS,SawaY,etal.Percutaneouscardiopulmonary

supportwithheparin-coatedcircuitsinpostcardiotomycardiogenicshoc

k.Efficacyandcomparisonwithleftheartbypass[J].JpnJThoracCa

rdiovascSurg2000May;48(5):274-279.



[26]EdmundsLH.Surface-boundheparin:panaceaorperil[J]AnnThora

cSurg1994,58:285-286.



[27]CheungAT,LevinSK,WeissSJ,etal.Intracardiacthrombus:ari

skofincompleteanticoagulationforcardiacoperations[J].AnnThora

cSurg1994,58:541-542.



[28]MuehrckeD,McCarthyPM,MarchantKK,etal.Biocompatibilityof

heparin-coatedextracorporealbypasscircuits:arandomized,maskedclini

caltrial[J].JThoracCardiovascSurg1996,112:472-483.



[29]SchreursHH,WijersMJ,GuYJ,etal.Heparin-coatedbypasscircu

it:effectsoninflammatoryresponseinpediatriccardiacoperations[J

].AnnToracSurg1998,66:166-171.



[30]AshrafS,TianY.Releaseofproinflammatorycytokinesduringped

iatricCPB:heparin-bondedvursusnonbondedoxygenetors[J].AnnThora

cSurg1997,64:1790-1794.



[31]EdmundsLH,Jr.Breakingtheblood-biomaterialbalance[J].ASA

IOJ1995,41:824-830.



[32]qvrumE,HolenEA,TangenG,etal.HeparinizedCPBandfullsys

temheparindosemarginallyimproveclinicalperformance[J].AnnThor

acSurg1996,62:1128-1133.



[33]BaufretonC,LeBesneraisP,JansonP,etal.Clinicaloutcomeaf

tercoronarysurgerywithheparin-coatedextracorporealcircuits[J].

Perfusion1996,11:437-443.



[34]OlssonC,SiegbahnA,HenzeA,etal.Heparin-coatedcardiopulmon

arybypasscircuitsreducecirculatingcomplementfactorsandinterleuk

in-6inpaediatricheartsurgery.ScandCardiovascJ2000,34(1):33-40.



[35]MullenJC,BentleyMJ,GelfandET.Coronaryarterybypasssurgery

withheparin-coatedperfusioncircuitsandlow-doseheparinization[J]

.CanJSurg2002Jun;45(3):166-172.



[36]TayamaE,HayashidaN,AkasuK,etal.Biocompatibilityofhepari

n-coatedextracorporealbypasscircuits:newheparinbondedbiolinesys

tem[J].ArtifOrgans2000Aug;24(8):618-623.



[37]VanderLindenJ,JinderD,ThelinS,etal.Heprin-coatedcardio

pulmonarycircuitsprotectagainstimpairedcognitivefunctionthreemo

nthsaftercoronaryarterybypassgrafting[J].Perfusion,1993,8:25

0.



[38]RanuciM,CirriS,ContiDetal.BeneficialeffectsofDurafloII

heparin-coatedcircuitsonpostperfusionlungdysfunction[J].AnnT

oracSurg1996,61:76-81.



[39]SteinbergJB,KapelanskiDP,OlsonJD,etal.Cytokineandcomple

mentlevelsinpatientsundergoingCPB[J].JThoracCardiovascSurg,

1993,106:1006-1016.



[40]RanucciM,MazzuccoA,PessottoR,etal.Heparin-coatscircuits

forhigh-riskpatients:amulticenter,prospective,randomizedtrial[J

].AnnThoracSurg1999,67:994-1000.



[41]McCarthyPM,YaredJPP,FosterRC,etal.Aprospectiverandomiz

edtrialofDurafloIIheparin-coatedcircuitsincardiacreoperation[

J].AnnThoracSurg1999,67:1268-1273.



[42]JansenPGM,BaufretonC,BesnaraisPL,etal.Heparin-coatedcir

cuitsandaprotininprimeforCABG[J].AnnThoracSurg1996,61:1363-

1366.



[43]HamadaY,KawachiK,NakataT.Antiinflammatoryeffectofheparin

-coatedcircuitswithleukocyte-depletingfiltersincoronarybypasssu

rgery[J].ArtifOrgans2001Dec;25(12):1004-1008.

上一页  [1] [2]